Paper32674367
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
Pajares M and 4 others. Cells, 2020. Cited by 643 papers, by iCite.
Cite this record
ConductScience Library. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications. Papers, record 32674367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32674367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammation | Major topic |
| Parkinson Disease | Major topic |
| Animals | |
| Blood-Brain Barrier | |
| Humans | |
| Immunomodulation | |
| Microglia | |
| Transcription, Genetic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06977204 | Physical Activity on Neuroinflammation in Parkinson's Disease | Results |
Source ClinicalTrials.gov
References255
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19551455 | CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease. | Neurotox Res | 2009 | https://conductscience.org/library/papers/19551455 | PubMed |
| 2 | 27478526 | An integrative microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development. | Biomicrofluidics | 2016 | https://conductscience.org/library/papers/27478526 | PubMed |
| 3 | 16611810 | Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. | J Neurosci | 2006 | https://conductscience.org/library/papers/16611810 | PubMed |
| 4 | 29507103 | Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. | Pharmacol Rev | 2018 | https://conductscience.org/library/papers/29507103 | PubMed |
| 5 | 28586827 | Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. | JAMA Neurol | 2017 | https://conductscience.org/library/papers/28586827 | PubMed |
| 6 | 24685620 | Metabolic tinkering by the gut microbiome: Implications for brain development and function. | Gut Microbes | 2014 | https://conductscience.org/library/papers/24685620 | PubMed |
| 7 | 28649611 | LRRK2 levels in immune cells are increased in Parkinson's disease. | NPJ Parkinsons Dis | 2017 | https://conductscience.org/library/papers/28649611 | PubMed |
| 8 | 25693054 | Microglia and neuroprotection. | J Neurochem | 2016 | https://conductscience.org/library/papers/25693054 | PubMed |
| 9 | 26498406 | Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. | Curr Opin Pharmacol | 2016 | https://conductscience.org/library/papers/26498406 | PubMed |
| 10 | 18504291 | Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. | Brain | 2008 | https://conductscience.org/library/papers/18504291 | PubMed |
| 11 | 29786072 | MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. | Cell Death Differ | 2019 | https://conductscience.org/library/papers/29786072 | PubMed |
| 12 | 30474172 | Immune system responses in Parkinson's disease: Early and dynamic. | Eur J Neurosci | 2019 | https://conductscience.org/library/papers/30474172 | PubMed |
| 13 | 30610225 | Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30610225 | PubMed |
| 14 | 17686182 | Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences. | BMC Genomics | 2007 | https://conductscience.org/library/papers/17686182 | PubMed |
| 15 | 23847046 | DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes. | Hum Mol Genet | 2013 | https://conductscience.org/library/papers/23847046 | PubMed |
| 16 | 18582534 | Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. | Neurosci Lett | 2008 | https://conductscience.org/library/papers/18582534 | PubMed |
| 17 | 21619488 | Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond. | Antioxid Redox Signal | 2012 | https://conductscience.org/library/papers/21619488 | PubMed |
| 18 | 31275235 | Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. | Front Neurol | 2019 | https://conductscience.org/library/papers/31275235 | PubMed |
| 19 | 12846989 | The role of glial reaction and inflammation in Parkinson's disease. | Ann N Y Acad Sci | 2003 | https://conductscience.org/library/papers/12846989 | PubMed |
| 20 | 25411471 | The gut microbiota influences blood-brain barrier permeability in mice. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/25411471 | PubMed |
Cited by452
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 643 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42918802 | Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson's disease. | Commun Biol | 2026 | https://conductscience.org/library/papers/42918802 | PubMed |
| 42905318 | Failure of Neuroinflammatory Resolution in Brain Aging: Molecular Mechanisms and an Integrative Framework of Microglial Inflammometabolic Locking. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42905318 | PubMed |
| 42898226 | Targeting BCL11B-mediated JAK2/STAT3 activation: A novel therapeutic strategy for Parkinson's disease. | iScience | 2026 | https://conductscience.org/library/papers/42898226 | PubMed |
| 42821203 | Exploring the Potential Neurotoxic Links Between 6PPD/6PPD-Q and Parkinson's Disease Through Network Toxicology and Multi-Dimensional Bioinformatics Analysis. | Neurotox Res | 2026 | https://conductscience.org/library/papers/42821203 | PubMed |
| 42798987 | Neuroinflammation and metabolic reprogramming in Parkinson's disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42798987 | PubMed |
| 42676507 | Role of STX1A in Parkinson's disease: evidence, mechanistic hypotheses, and translational perspectives. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42676507 | PubMed |
| 42669843 | Olfactory proteomics reveals the capacity of the HDAC1 inhibitor pyroxamide to halt the α-synuclein preformed fibrils-induced damage in nasal epithelial, microglial and dopaminergic neuronal cell lines. | Brain Pathol | 2026 | https://conductscience.org/library/papers/42669843 | PubMed |
| 42642961 | Lipid Metabolism in Central Nervous System Diseases: Pathological Mechanisms and Therapeutic Advances. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42642961 | PubMed |
| 42611157 | The Neuroimmune Duality of CD4⁺ T Cells: Drivers of Damage and Repair in the Brain. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42611157 | PubMed |
| 42588095 | Potential Relevance of Amazonian Diet Components in Parkinson's Disease: An Integrative Review with Multivariate Analysis. | Nutrients | 2026 | https://conductscience.org/library/papers/42588095 | PubMed |
| 42557483 | Cross-link Between CircRNAs and Neuroinflammation in Parkinson's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42557483 | PubMed |
| 42511733 | Hirudin as a Therapeutic and Brain-Delivery Platform: From Stroke to Central Nervous System Disorders. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511733 | PubMed |
| 42510886 | Mitochondrial Quality Control and Pathogenic Signaling Networks in Parkinson's Disease. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42510886 | PubMed |
| 42510637 | Neuroprotective Effects of Polyphenol-Rich Corinthian Currant Against a Rotenone Parkinson's Disease Model: Mitigation of MAO-B and Pro-Inflammatory Cytokines Upregulation in Motor and Limbic Brain Regions. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42510637 | PubMed |
| 42499343 | Imaging patterns and genetic associations of brain atrophy across distinct symptom stages in Parkinson's disease. | Neuroprotection | 2026 | https://conductscience.org/library/papers/42499343 | PubMed |
| 42491523 | Antibody screening identifies HERV-K-related immune responses as candidate biomarkers in Parkinson's disease. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42491523 | PubMed |
| 42486828 | [CHIR99021 alleviates neuroinflammation in a mouse model of Parkinson's disease by inhibiting the GSK-3β/NF-κB pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | https://conductscience.org/library/papers/42486828 | PubMed |
| 42470822 | Recent advances in methotrexate pharmacology and potential therapeutic uses in age-related cardiometabolic and neurodegenerative diseases. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42470822 | PubMed |
| 42470585 | C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats. | Neurotox Res | 2026 | https://conductscience.org/library/papers/42470585 | PubMed |
| 42461319 | Neuroimmune Regulation of NLRP3 Signalling in Parkinson's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42461319 | PubMed |
Genes53
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32674367
GET https://conductscience.org/api/papers/v1/32674367/references?page=2